Wall Street Advisor Initiates Coverage On DOR BioPharma, Inc. With A Speculative Buy Recommendation

NEW YORK--(BUSINESS WIRE)--Wall Street Advisor has initiated coverage of DOR BioPharma, Inc. (OTCBB:DORB) with a Speculative Buy recommendation. The report may be found at http://www.wallstreetadvisor.com/DORB_Research_Report.pdf.